Odyssey Therapeutics Raises $213M in Series D

Odyssey Therapeutics has successfully raised $213M in a Series D from multiple investors.

Company Overview

Odyssey Therapeutics is a HealthTech company headquartered in Boston, MA, founded in 2020 with 150+ employees.

Autoimmune disease therapeutic development company

Fundraising Details

Amount Raised: $213M
Round Type: Series D
Date: 2025-09-15
Investors: Multiple investors

About Odyssey Therapeutics

Autoimmune disease therapeutic development company The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.

Key Information

Headquarters: Boston, MA
Founded: 2020
Team Size: 150+
Industry: HealthTech

What This Means

This funding round demonstrates strong investor confidence in Odyssey Therapeutics's vision and execution. The capital will likely be used to:

Scale Operations: Expand the team and operational capacity
Product Development: Enhance existing products and develop new features
Market Expansion: Enter new markets and strengthen presence in existing ones
Technology Investment: Invest in infrastructure and technology capabilities

Industry Context

The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Odyssey Therapeutics's successful fundraising reflects the strong fundamentals and growth potential in this space.

Looking Ahead

With this new capital, Odyssey Therapeutics is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.

This fundraising news was reported on 2025-09-15. For more information about Odyssey Therapeutics, visit their headquarters at Boston, MA.

Odyssey Therapeutics